Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines

被引：3
作者：
Amano, Masayuki [1 ,5 ]
Ichikawa, Yasuko [2 ]
Uemura, Yukari [3 ]
Matsumoto, Shota [1 ,2 ]
Maeda, Kenji [4 ]
Matsushita, Shuzo
Shimada, Shinya [2 ]
Mitsuya, Hiroaki [4 ]
机构：
[1] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Dept Clin Retrovirol, Kumamoto, Japan
[2] Kumamoto Gen Hosp, Japan Community Hlth Care Org, Kumamoto, Japan
[3] Natl Ctr Global Hlth & Med NCGM, Ctr Clin Sci, Dept Data Sci, Tokyo, Japan
[4] NCGM Res Inst, Dept Refractory Viral Infect, Tokyo, Japan
[5] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Dept Clin Retrovirol, 2-2-1 Honjo,Cyuou Ku, Kumamoto 8600811, Japan
来源：
JOURNAL OF INFECTION | 2023年 / 86卷 / 05期
关键词：
D O I：
10.1016/j.jinf.2023.01.038
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E130 / E132
页数：3
相关论文
共 6 条
  • [1] Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine
    Amano, Masayuki
    Otsu, Sachiko
    Ichikawa, Yasuko
    Higashi-Kuwata, Nobuyo
    Matsushita, Shuzo
    Shimada, Shinya
    Mitsuya, Hiroaki
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 227 (01) : 161 - 163
  • [2] Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants
    Amano, Masayuki
    Otsu, Sachiko
    Maeda, Kenji
    Uemura, Yukari
    Shimizu, Yosuke
    Omata, Kazumi
    Matsuoka, Masao
    Shimada, Shinya
    Mitsuya, Hiroaki
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan
    Amano, Masayuki
    Maeda, Kenji
    Tsuchiya, Kiyoto
    Shimada, Shinya
    Mitsuya, Hiroaki
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (11) : 2038 - 2039
  • [4] Maeda K, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-01930-y, 10.1101/2021.07.27.21261237]
  • [5] Pozo-Balado MDM, 2022, J INFECT, VS0163-4453, P00692
  • [6] World Health Organisation (WHO), 2020, COVID 19 STRAT UPD
1